The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease — Stella

Recruiting

Back to Alzheimer's Disease trials

Trial locations(1 site)

China

Xuanwu Hospital of Capital Medical University, Beijing, Beijing Municipality

Key details

Sponsor

Capital Medical University

Collaborators

Shandong Provincial Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~3,200 participants

Started

September 2018

Primary completion

September 2027

Age range

55 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov